| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 04/02/2009 | CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | CA2700539A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 04/02/2009 | CA2700292A1 Halogen alkoxy spirocyclic tetramic and tetronic acid derivatives |
| 04/02/2009 | CA2700199A1 Combination therapy related to serotonin dual action compounds |
| 04/01/2009 | EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists |
| 04/01/2009 | EP2042488A1 Matrix metalloproteinase inhibitors |
| 04/01/2009 | EP2042480A1 Aminoindan derivative or salt thereof |
| 04/01/2009 | EP2041086A1 Indole compounds |
| 04/01/2009 | EP1773770B1 Indole-2-carboxamidine derivatives as nmda receptor antagonists |
| 04/01/2009 | EP1646661B1 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom |
| 04/01/2009 | CN101397295A 2-dihydroindolemanone derivates as histone deacetylase inhibitor, preparation method and use thereof |
| 04/01/2009 | CN100473654C S type 4-substituted hydroxypyranoindolidine compound and derivatives and preparation thereof |
| 04/01/2009 | CN100473645C Processes for preparation of bicyclic compounds and intermediates therefor |
| 04/01/2009 | CN100473609C Synthetic porous crystalline MCM-68, and synthesis and use thereof |
| 03/31/2009 | US7511072 7-amido-isoindolyl compounds and methods of its use |
| 03/31/2009 | US7511069 Indazole compounds as β3 andrenoceptor agonist |
| 03/31/2009 | US7511043 farnesoid X receptor; to mitigate and thereby treat hypercholesterolemia; antagonists, which block the negative feedback downregulation of cyp7a expression produced by certain cholic acids |
| 03/31/2009 | US7510781 Organic luminescence device (OLED) containing both a 5,5'-spirobi(dibenzosilole) compound and a diarylaminofluorene compound; spiro compounds have improved electron-transporting property, luminescence, and durability |
| 03/31/2009 | US7510700 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 03/26/2009 | WO2009038847A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/26/2009 | WO2009038157A1 2,3-dihydroiminoisoindole derivative |
| 03/26/2009 | WO2009038038A1 Acetylene compound, salt thereof, condensate thereof, and composition thereof |
| 03/26/2009 | WO2009037718A2 Process for preparing 3-(2-(dimethylamino)ethyl)-n- methyl-1h-indole-5-methanesulfonamide and product thereof |
| 03/26/2009 | WO2009036955A1 Naphtyl-substituted sulfonamides |
| 03/26/2009 | WO2009016560A3 Trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 03/26/2009 | WO2009016253A3 Cyanomethyl substituted n-acyl tryptamines |
| 03/26/2009 | WO2008007211A8 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 03/26/2009 | US20090082577 Fluorescent probes for biological studies |
| 03/26/2009 | US20090082576 Synthetic route to abcd-porphyrins |
| 03/26/2009 | US20090082419 Deuterium-enriched tegaserod |
| 03/26/2009 | US20090082418 Deuterium-enriched fluvastatin |
| 03/26/2009 | US20090082395 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082393 New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them |
| 03/26/2009 | US20090082392 Substituted Carboxylic Acids |
| 03/26/2009 | US20090082377 Matrix Metalloproteinase Inhibitors |
| 03/26/2009 | US20090082368 Methods of modulating neurotrophin-mediated activity |
| 03/26/2009 | US20090082212 System and methods for nucleic acid sequencing of single molecules by polymerase synthesis |
| 03/26/2009 | CA2691031A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/25/2009 | EP2039697A1 Fluoroboron compound, aminomethylating agent for aromatic ring comprising the compound, and process for production of compound having aminomethyl-aromatic ring using the aminomethylating agent |
| 03/25/2009 | EP2039683A2 Vasculostatic agents and methods of use thereof |
| 03/25/2009 | EP2039682A1 Salts for adding angiotensin conversion enzyme inhibitors to NO-donor acids, method of preparing same and pharmaceutical compositions containing them |
| 03/25/2009 | EP2039354A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same |
| 03/25/2009 | EP2038254A2 Bicyclic compositions and methods for modulating a kinase cascade |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1472228B1 Process for the manufacture of hmg-coa reductase inhibitors |
| 03/25/2009 | CN101395134A 17 beta hsd type 5 inhibitor |
| 03/25/2009 | CN101395133A Sigma receptor compounds |
| 03/25/2009 | CN101391977A Method for synthesizing 1,3-diiminoisoindole |
| 03/25/2009 | CN101391976A Process for the preparation of N-amino substituted heterocyclic compounds |
| 03/25/2009 | CN101391973A Salts for adding angiotensin conversion enzyme inhibitors to no-donor acids, method of preparing same and pharmaceutical compositions containing them |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/25/2009 | CN100471837C Process for preparing certain pyrrolotriazine compounds |
| 03/24/2009 | US7507860 Androgen modulators |
| 03/24/2009 | US7507836 Benzamide modulators of metabotropic glutamate receptors |
| 03/24/2009 | US7507835 e.g. [2-(1-(Benzenesulfonyl)-1H-indol-3-yloxy)ethyl]dimethylamine; serotonin, melatonin receptor ligand; antidepressant, anxiolytic agent; cognition activator; psychosis, schizophrenia, migraine headache, drug addiction, convulsions, osteoporosis, ischemic stroke, Alzheimer's, Parkinson's diseases |
| 03/24/2009 | US7507759 Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione |
| 03/24/2009 | US7507758 4-alkyl-/4-alkenyl-/4-alkynyl methyl/-1-aryl-cyclohexylamine compounds |
| 03/24/2009 | CA2431100C Dihydroindole and tetrahydroquinoline derivatives |
| 03/19/2009 | WO2009035951A2 Soluble epoxide hydrolase inhibitors |
| 03/19/2009 | WO2009035836A1 A method for making n-2,3-dibromopropyl-4-5-dibromohexahydrophthalimide |
| 03/19/2009 | WO2009035542A2 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/19/2009 | WO2009035157A1 Therapeutic and/or prophylactic agent for lower urinary tract symptoms after radiotherapy |
| 03/19/2009 | WO2009035024A1 Fullerene derivative |
| 03/19/2009 | WO2009035017A1 Fullerene derivative |
| 03/19/2009 | WO2009034457A1 Organic compounds useful for the treatment of neurodegenerative diseases, uses and methods for the preparation thereof |
| 03/19/2009 | WO2009013299A3 Novel bradykinin b1 antagonists |
| 03/19/2009 | WO2008110690A3 Novel indole derivatives, methods for preparing same, and use thereof particularly as antibacterial agents |
| 03/19/2009 | WO2008037258A8 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 03/19/2009 | US20090076283 Method of crystallizing carvedilol phosphate and the product thereof |
| 03/19/2009 | US20090076278 Methine dyes and uses of the same |
| 03/19/2009 | US20090076271 Process for preparing intermediates of HMG-CoA reductase inhibitors |
| 03/19/2009 | US20090076235 Copolymerizable methine and anthraquinone compounds and articles containing them |
| 03/19/2009 | US20090076124 Deuterium-enriched ropinirole |
| 03/19/2009 | US20090076123 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 03/19/2009 | US20090076121 Deuterium-enriched sumatriptan |
| 03/19/2009 | US20090076119 Deuterium-enriched ramipril |
| 03/19/2009 | US20090076118 Deuterium-enriched saxagliptin |
| 03/19/2009 | US20090076117 Deuterium-enriched laropiprant |
| 03/19/2009 | US20090076116 Deuterium-enriched carvediolo |
| 03/19/2009 | US20090076115 Photosensitizers for Targeted Photodynamic Therapy |
| 03/19/2009 | US20090076005 Kinase inhibitor compounds |
| 03/19/2009 | US20090076004 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics |
| 03/19/2009 | US20090075996 Heterotetracyclic compounds as tpo mimetics |
| 03/19/2009 | US20090075987 Alkylacetylene substituted acyltryptophanols |
| 03/19/2009 | US20090075985 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | US20090075938 Treatment of duchenne muscular dystrophy |
| 03/19/2009 | US20090074887 For control of phytopathogenic fungi; synergistic |
| 03/19/2009 | US20090074673 Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques |
| 03/19/2009 | DE102004022915B4 Indolstyryl-Verbindung zur Verwendung in Aufnahmemedien und Verfahren zu dessen Herstellung Indolstyryl compound for use in recording media and methods for its preparation |
| 03/19/2009 | CA2697752A1 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/18/2009 | EP2036889A2 Substituted indoles and a method for the production and use thereof |
| 03/18/2009 | EP2036888A1 Naphthyl-substituted sulfonamides |
| 03/18/2009 | EP2036887A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 03/18/2009 | EP2036886A1 Association between an anti-atherothrombotic and an angiotensin conversion enzyme inhibitor |
| 03/18/2009 | EP2035379A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 03/18/2009 | EP2035378A1 Substituted isoindoles as bace inhibitors and their use |
| 03/18/2009 | EP2035377A1 Indole derivatives and their use as thyroid receptor ligands |
| 03/18/2009 | EP2035376A1 Indoline amide derivatives as ep4 receptor ligands |
| 03/18/2009 | EP2035370A2 Tetralin and indane derivatives and uses thereof |